Prognostic and Predictive Biomarkers in Ovarian Cancers
Recruiting now · Not applicable
Conditions studied: Ovarian Cancer
In brief
The investigators therefore propose to conduct a biological study of prospectively collected patient tumour samples, ascites, blood and other residual samples (feces, urine, vaginal smear) throughout the disease course where markers (at diagnosis and their change with treatment) will be correlated to outcome in order to investigate how genetic diversity in OC prior to treatment and adaptation following treatment contribute to chemotherapy resistance. In addition freshly collected ascitic samples (and tumour samples) will be subjected to ex vivo DNA repair functional assays and isolated in primary culture (and established as xenografts) for target validation experiments.
Key facts
- Study ID
- NCT03010124
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
- People needed
- 350
- Starts
- 2016-09-26
- Expected to finish
- 2032-09-01
- Last updated by the study team
- 2026-03-20
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- New patient with a diagnosis of OC, or
- Previously treated patient with frozen or formalin fixed paraffin embedded primary tumour sample available that can be retrieved by the center presenting with progressive disease, and consenting to CT guided biopsy of relapsed disease, or
- Previously treated patient with frozen or formalin fixed paraffin embedded primary tumour sample available that can be retrieved by the center scheduled for surgery for relapsed disease.
- Signed informed consent
- Age ≥ 18
- Patient affiliated to a social security regimen or beneficiary of the same
You may not qualify if…
- Patients who do not fit the inclusion criteria and those who refuse an antitumoral treatment;
- Coagulation abnormalities that contra-indicates the biopsy
Where it is running
- Gustave Roussy — Villejuif, Val de Marne, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.